Large-scale testing (Phase 3)Study completedNCT01721746
What this trial is testing
Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)
Who this might be right for
Unresectable or Metastatic Melanoma
Bristol-Myers Squibb 405